TDAC
NASDAQ · N/A
Translational Development Ac
$10.64
+0.01 (+0.05%)
Open$10.64
Previous Close$10.64
Day High$10.64
Day Low$10.64
52W High$10.69
52W Low$10.15
Volume—
Avg Volume28.7K
Market Cap233.10M
P/E Ratio36.64
EPS$0.29
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 211.68M | 197.91M | 234.06M |
| Net Income | 7.59M | 7.31M | 8.97M |
| Profit Margin | 3.6% | 3.7% | 3.8% |
| EBITDA | 13.67M | 12.28M | 15.52M |
| Free Cash Flow | 6.88M | 4.06M | 6.97M |
| Rev Growth | +3.0% | +7.4% | -1.8% |
| Debt/Equity | 0.09 | 0.09 | 0.09 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $7.86 | -10.68% | — | 5.22B |
| PICS | Pics Nv | $10.49 | -9.22% | — | 1.50B |
| DMII | Drugs Made In America Acquis | $10.03 | +0.00% | 152.6 | 638.91M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.84B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.54 | -0.01% | 62.2 | 606.86M |
| CEPF | Cantor Equity Partners-Cl A | $10.32 | +0.10% | 96.1 | 589.22M |